[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Actinic (Solar) Keratosis Treatment Market Status and Outlook 2018-2025

August 2018 | 154 pages | ID: G9CEEC8327EEN
99Strategy

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies
  • 3M Drug Delivery Systems
  • Athenex Inc
  • CritiTech Inc
  • Foamix Pharmaceuticals Ltd
  • G&E Herbal Biotechnology Co Ltd
  • Galderma SA
  • Laboratories Ojer Pharma SL
  • LEO Pharma A/S
  • Novartis AG
  • Oncology Research International Ltd
  • Promius Pharma LLC
  • Valeant Pharmaceuticals International Inc
  • Vectura Group Plc
Market by Type
  • 854-A
  • ACT-01
  • AD-17137
  • Celecoxib
  • DFD-08
  • GDC-695
  • Others
Market by Application
  • Hospital
  • Clinic
  • Others
PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Actinic (Solar) Keratosis Treatment Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 854-A
  3.1.2 ACT-01
  3.1.3 AD-17137
  3.1.4 Celecoxib
  3.1.5 DFD-08
  3.1.6 GDC-695
  3.1.7 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hospital
  4.1.2 Clinic
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 854-A Production by Region
    6.1.1.2 ACT-01 Production by Region
    6.1.1.3 AD-17137 Production by Region
    6.1.1.4 Celecoxib Production by Region
    6.1.1.5 DFD-08 Production by Region
    6.1.1.6 GDC-695 Production by Region
    6.1.1.7 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hospital Production by Region
    6.1.2.2 Clinic Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 854-A Demand by Region
    6.2.1.2 ACT-01 Demand by Region
    6.2.1.3 AD-17137 Demand by Region
    6.2.1.4 Celecoxib Demand by Region
    6.2.1.5 DFD-08 Demand by Region
    6.2.1.6 GDC-695 Demand by Region
    6.2.1.7 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hospital Demand by Region
    6.2.2.2 Clinic Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 3M Drug Delivery Systems
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Athenex Inc
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 CritiTech Inc
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Foamix Pharmaceuticals Ltd
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 G&E Herbal Biotechnology Co Ltd
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Galderma SA
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Laboratories Ojer Pharma SL
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 LEO Pharma A/S
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Novartis AG
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Oncology Research International Ltd
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Promius Pharma LLC
8.12 Valeant Pharmaceuticals International Inc
8.13 Vectura Group Plc

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

LIST OF TABLES

Table Actinic (Solar) Keratosis Treatment Industry Dynamics & Regulations List
Table Global Actinic (Solar) Keratosis Treatment Sales Revenue, Cost and Margin, 2015-2018E
Table Global Actinic (Solar) Keratosis Treatment Market Status by Type 2015-2018E, in USD Million
Table Global Actinic (Solar) Keratosis Treatment Market Status by Application 2015-2018E, in USD Million
Table Global Actinic (Solar) Keratosis Treatment Market Status by Application 2015-2018E, in Volume
Table Global Actinic (Solar) Keratosis Treatment Market by Region 2015-2018E, in USD Million
Table Global Actinic (Solar) Keratosis Treatment Market Share by Region in 2018, in USD Million
Table Global Actinic (Solar) Keratosis Treatment Market by Region 2015-2018E, in Volume
Table Global Actinic (Solar) Keratosis Treatment Market Share by Region in 2018, in Volume
Table 854-A Production Value by Region 2015-2018E, in USD Million
Table 854-A Production Volume by Region 2015-2018E, in Volume
Table ACT-01 Production Value by Region 2015-2018E, in USD Million
Table ACT-01 Production Volume by Region 2015-2018E, in Volume
Table AD-17137 Production Value by Region 2015-2018E, in USD Million
Table AD-17137 Production Volume by Region 2015-2018E, in Volume
Table Celecoxib Production Value by Region 2015-2018E, in USD Million
Table Celecoxib Production Volume by Region 2015-2018E, in Volume
Table DFD-08 Production Value by Region 2015-2018E, in USD Million
Table DFD-08 Production Volume by Region 2015-2018E, in Volume
Table GDC-695 Production Value by Region 2015-2018E, in USD Million
Table GDC-695 Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Hospital Production Value by Region 2015-2018E, in USD Million
Table Hospital Production Volume by Region 2015-2018E, in Volume
Table Clinic Production Value by Region 2015-2018E, in USD Million
Table Clinic Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table 854-A Market Size by Region 2015-2018E, in USD Million
Table 854-A Market Size by Region 2015-2018E, in Volume
Table ACT-01 Market Size by Region 2015-2018E, in USD Million
Table ACT-01 Market Size by Region 2015-2018E, in Volume
Table AD-17137 Market Size by Region 2015-2018E, in USD Million
Table AD-17137 Market Size by Region 2015-2018E, in Volume
Table Celecoxib Market Size by Region 2015-2018E, in USD Million
Table Celecoxib Market Size by Region 2015-2018E, in Volume
Table DFD-08 Market Size by Region 2015-2018E, in USD Million
Table DFD-08 Market Size by Region 2015-2018E, in Volume
Table GDC-695 Market Size by Region 2015-2018E, in USD Million
Table GDC-695 Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Hospital Market Size by Region 2015-2018E, in USD Million
Table Hospital Market Size by Region 2015-2018E, in Volume
Table Clinic Market Size by Region 2015-2018E, in USD Million
Table Clinic Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalActinic (Solar) Keratosis Treatment Forecast by Type 2019F-2025F, in USD Million
Table Actinic (Solar) Keratosis Treatment Forecast by Type 2019F-2025F, in Volume
Table Actinic (Solar) Keratosis Treatment Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Actinic (Solar) Keratosis Treatment Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Actinic (Solar) Keratosis Treatment Market Forecast by Region 2019F-2025F, in USD Million
Table Actinic (Solar) Keratosis Treatment Market Forecast by Region 2019F-2025F, in Volume
Table 3M Drug Delivery Systems Information
Table Actinic (Solar) Keratosis Treatment Sales, Cost, Margin of 3M Drug Delivery Systems
Table Athenex Inc Information
Table Actinic (Solar) Keratosis Treatment Sales, Cost, Margin of Athenex Inc
Table CritiTech Inc Information
Table Actinic (Solar) Keratosis Treatment Sales, Cost, Margin of CritiTech Inc
Table Foamix Pharmaceuticals Ltd Information
Table Actinic (Solar) Keratosis Treatment Sales, Cost, Margin of Foamix Pharmaceuticals Ltd
Table G&E Herbal Biotechnology Co Ltd Information
Table Actinic (Solar) Keratosis Treatment Sales, Cost, Margin of G&E Herbal Biotechnology Co Ltd
Table Galderma SA Information
Table Actinic (Solar) Keratosis Treatment Sales, Cost, Margin of Galderma SA
Table Laboratories Ojer Pharma SL Information
Table Actinic (Solar) Keratosis Treatment Sales, Cost, Margin of Laboratories Ojer Pharma SL
Table LEO Pharma A/S Information
Table Actinic (Solar) Keratosis Treatment Sales, Cost, Margin of LEO Pharma A/S
Table Novartis AG Information
Table Actinic (Solar) Keratosis Treatment Sales, Cost, Margin of Novartis AG
Table Oncology Research International Ltd Information
Table Actinic (Solar) Keratosis Treatment Sales, Cost, Margin of Oncology Research International Ltd
Table Promius Pharma LLC Information
Table Actinic (Solar) Keratosis Treatment Sales, Cost, Margin of Promius Pharma LLC
Table Valeant Pharmaceuticals International Inc Information
Table Actinic (Solar) Keratosis Treatment Sales, Cost, Margin of Valeant Pharmaceuticals International Inc
Table Vectura Group Plc Information
Table Actinic (Solar) Keratosis Treatment Sales, Cost, Margin of Vectura Group Plc
Table Global Actinic (Solar) Keratosis Treatment Sales Revenue by Company 2015-2017, in USD Million
Table Global Actinic (Solar) Keratosis Treatment Sales Volume by Company 2015-2017, in Volume
Table Global Actinic (Solar) Keratosis Treatment Sales Volume by Company in 2018, in Volume

LIST OF FIGURES

Figure Actinic (Solar) Keratosis Treatment Picture
Figure Actinic (Solar) Keratosis Treatment Industry Chain Diagram
Figure Global Actinic (Solar) Keratosis Treatment Sales Revenue 2015-2018E, in USD Million
Figure Global Actinic (Solar) Keratosis Treatment Sales Volume 2015-2018E, in Volume
Figure Global Actinic (Solar) Keratosis Treatment Market Status by Type 2015-2018E, in Volume
Figure North America Actinic (Solar) Keratosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure North America Actinic (Solar) Keratosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure Europe Actinic (Solar) Keratosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Europe Actinic (Solar) Keratosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Actinic (Solar) Keratosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure South America Actinic (Solar) Keratosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure South America Actinic (Solar) Keratosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure Middle East Actinic (Solar) Keratosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Actinic (Solar) Keratosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure Africa Actinic (Solar) Keratosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Africa Actinic (Solar) Keratosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure Global Actinic (Solar) Keratosis Treatment Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Actinic (Solar) Keratosis Treatment Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Actinic (Solar) Keratosis Treatment Sales Price Forecast 2019F-2025F
Figure Global Actinic (Solar) Keratosis Treatment Gross Margin Forecast 2019F-2025F
Figure Global Actinic (Solar) Keratosis Treatment Sales Revenue by Company in 2018, in USD Million
Figure Global Actinic (Solar) Keratosis Treatment Price by Company in 2018
Figure Global Actinic (Solar) Keratosis Treatment Gross Margin by Company in 2018


More Publications